EMA Refused: Valdoxan (agomelatine) — Les Laboratoires Servier

View source ↗

Summary

The EMA refused the Valdoxan (agomelatine) application by Les Laboratoires Servier for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Valdoxan (agomelatine)

Snippet

Status: Refused. Therapeutic area: Depressive Disorder, Major. MAH: Les Laboratoires Servier. Decision date: 27/07/2006